These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4039669)

  • 1. Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Eur J Pharmacol; 1985 Feb; 109(1):81-9. PubMed ID: 4039669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of metoclopramide, sulpiride, and the stereoisomers of baclofen on amphetamine-induced behavior in the marmoset.
    Ridley RM; Scraggs PR; Baker HF
    Biol Psychiatry; 1980 Apr; 15(2):265-74. PubMed ID: 7191332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion.
    Moore S; Kenyon P
    Psychopharmacology (Berl); 1994 Feb; 114(1):123-30. PubMed ID: 7846194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoclopramide potentiates d-amphetamine-induced hypermotility and stereotypy in rat.
    Howard JL; Pollard GT; Craft RM; Rohrbach KW
    Pharmacol Biochem Behav; 1987 May; 27(1):165-9. PubMed ID: 3615538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R; Guerin JJ; Davis KL
    Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential behavioural interactions between the dopamine D-1 antagonist SCH 23390 and the dopamine D-2 antagonists metoclopramide and sulpiride in nonhabituated mice.
    Chandler CJ; Starr BS; Starr MS
    Pharmacol Biochem Behav; 1990 Feb; 35(2):285-9. PubMed ID: 2181484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible discrepancy between behavioral adequacy and motor automatisms in cats with phenamine-induced stereotypy].
    Tolpyshev BA; Smirnova LE; Arushanian EB
    Biull Eksp Biol Med; 1981 Aug; 92(8):46-8. PubMed ID: 7197561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of amphetamine-induced locomotor activity and stereotypy in rats by spiroperidol but not by an atypical neuroleptic, thioridazine.
    Bentall AC; Herberg LJ
    Neuropharmacology; 1980 Aug; 19(8):699-703. PubMed ID: 7191488
    [No Abstract]   [Full Text] [Related]  

  • 12. Amphetamine-induced locomotor stereotypy in rats is reduced by a D1 but not a D2 antagonist.
    Fritts ME; Mueller K; Morris L
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1015-9. PubMed ID: 9408208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.
    Mueller K
    Pharmacol Biochem Behav; 1993 May; 45(1):71-6. PubMed ID: 8100075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dissociation between movement disorders and EEG shifts in amphetamine-induced stereotypy in the cat].
    Tolpyshev BA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1986; 36(3):545-53. PubMed ID: 3751303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J
    Eur J Pharmacol; 1983 May; 90(1):47-55. PubMed ID: 6135618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity.
    Gordon JH; Clopton JK; Curtin JC; Koller WC
    Pharmacol Biochem Behav; 1987 Feb; 26(2):223-8. PubMed ID: 3575347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):411-5. PubMed ID: 3780853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of amphetamine-induced locomotor stereotypy in an open field.
    Mueller K; Kunko PM; Whiteside D; Haskett C
    Psychopharmacology (Berl); 1989; 99(4):501-7. PubMed ID: 2594917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.